Tinelli M, Michela http://orcid.org/0000-0002-8816-4389
Roddy, Aine
Knapp, Martin
Arango, Celso
Mendez, Maria Andreina
Cusack, James
Murphy, Declan
Canitano, Roberto
Oakley, Bethany
Quoidbach, Vinciane
Funding for this research was provided by:
Commission européenne Office Européen de Lutte Antifraude (n/a)
Article History
Accepted: 17 February 2023
First Online: 4 May 2023
Declarations
:
: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Dr. Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. Prof Murphy has been a consultant to or has received honoraria or grants from Servier, Roche, Clinical Research Associates, and Jaguar Theraputics. He has also received funding from the European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No 777394, Project AIMS-2-TRIALS).